185 related articles for article (PubMed ID: 17899514)
1. [Prevalence of hand dysfunction in cerebral palsy following Botulinum toxin therapy].
Alahmar-Bianchin M; Saraiva-Storti HC; Fornari-Chueri R; Lucato RV
Rev Neurol; 2007 Sep 16-30; 45(6):334-7. PubMed ID: 17899514
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
4. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
5. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
[TBL] [Abstract][Full Text] [Related]
6. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
7. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin Type A. Indications and results].
Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
11. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E
Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin type A in children with cerebral palsy.
Nolan KW; Cole LL; Liptak GS
Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
[No Abstract] [Full Text] [Related]
16. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy.
Park ES; Rha DW; Lee JD; Yoo JK; Chang WH
Neuropediatrics; 2009 Dec; 40(6):269-74. PubMed ID: 20446220
[TBL] [Abstract][Full Text] [Related]
17. The type A botulinum toxin in the treatment of spasticity in evolutive age.
Roccella M
Minerva Pediatr; 1999; 51(11-12):367-73. PubMed ID: 10768002
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
Gibson N; Graham HK; Love S
Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
[TBL] [Abstract][Full Text] [Related]
19. Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection.
Massin M; Allington N
J Pediatr Orthop; 1999; 19(3):362-5. PubMed ID: 10344321
[TBL] [Abstract][Full Text] [Related]
20. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
